embelin has been researched along with bicalutamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danquah, M; Duke, CB; Li, F; Mahato, RI; Miller, DD | 1 |
| Danquah, M; Duke, CB; Mahato, RI; Miller, DD; Patil, R | 1 |
2 other study(ies) available for embelin and bicalutamide
| Article | Year |
|---|---|
Micellar delivery of bicalutamide and embelin for treating prostate cancer.
Topics: Anilides; Animals; Antineoplastic Agents; Apoptosis; Base Sequence; Benzoquinones; Cell Line, Tumor; DNA Primers; Humans; Male; Mice; Mice, Nude; Micelles; Nitriles; Prostatic Neoplasms; Tosyl Compounds; Transplantation, Heterologous | 2009 |
Combination therapy of antiandrogen and XIAP inhibitor for treating advanced prostate cancer.
Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Cell Cycle; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Hydroxybutyrates; Male; Mice; Micelles; Nitriles; Prostate; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds; X-Linked Inhibitor of Apoptosis Protein | 2012 |